Therapeutic Asset Ratings

13,150 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Capecitabine PPoma	ECOG-ACRIN Cancer Research Group	P2	CCC (55)
Capecitabine Pancreatic Endocrine Carcinoma	Alliance for Clinical Trials in Oncology	P2	CCC (55)
Capecitabine Urinary Bladder Neoplasm	Merck Sharp & Dohme LLC	P2	CCC (55)
Capivasertib B-Cell Non-Hodgkin Lymphoma	AstraZeneca	P2	CCC (55)
Carboplatin Cholangiocarcinoma	Merck Sharp & Dohme LLC	P2	CCC (55)
Carboplatin Chronic Myelomonocytic Leukemia	OHSU Knight Cancer Institute	P2	CCC (55)
Catequentinib Chemotherapy-Induced Toxicity	Wenjun Cheng	P2	CCC (55)
Catequentinib Ovarian Clear Cell Adenocarcinoma	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P2	CCC (55)
Cbp 501 Malignant Pancreatic Neoplasm	CanBas Co. Ltd.	P2	CCC (55)
Cbx-12 Ovarian Carcinoma	Cybrexa Therapeutics	P2	CCC (55)
Cediranib Endometrioid Adenocarcinoma	National Cancer Institute (NCI)	P2	CCC (55)
Cenobamate Epilepsy	Brigham and Women's Hospital	P2	CCC (55)
Cetuximab Gastric Cancer	BeOne Medicines	P2	CCC (55)
Cetuximab Pancreatic Ductal Adenocarcinoma	Verastem, Inc.	P2	CCC (55)
Cis-Diamminedichloroplatinum Ii Castration-Resistant Prostate Carcinoma	Jonsson Comprehensive Cancer Center	P2	CCC (55)
Cis-Diamminedichloroplatinum Ii Colorectal Adenocarcinoma	Akeso	P2	CCC (55)
Cladribine Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	CCC (55)
Cladribine Myelodysplastic Syndrome With Excess Blasts-2	M.D. Anderson Cancer Center	P2	CCC (55)
Clofarabine Adult Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P2	CCC (55)
Clofarabine Therapy-Related Myeloid Neoplasm	M.D. Anderson Cancer Center	P2	CCC (55)
Clofarabine Chronic Myelomonocytic Leukemia	M.D. Anderson Cancer Center	P2	CCC (55)
Clofarabine Myeloproliferative Neoplasm	Memorial Sloan Kettering Cancer Center	P2	CCC (55)
Clofarabine Graft Versus Host Disease	Memorial Sloan Kettering Cancer Center	P2	CCC (55)
Clomiphene Citrate 46 XX Gonadal Dysgenesis	Ain Shams University	P2	CCC (55)
Cobimetinib Metastatic Melanoma	Hanmi Pharmaceutical Company Limited	P2	CCC (55)

Showing 2676 to 2700 of 13,150 assets

PreviousPage 108 of 526Next